Establishing evidence for the functionality of acai and Amazonian fruits
First written in FY2016. 11 of 25 entries say "Advanced", first in FY2017-Q2. Latest entry: FY2025-H1.
No other company in this theme has enough history to compare yet.
- FY2025-H1RestatedAnnual report
「In research into acai's haematopoietic function, the company is pursuing clinical experiments, identification of the causative substance and patenting in order to make the value demonstrated by its research results widely known to customers through functionality labelling.」
The company continues its policy of linking research into haematopoietic function to clinical experiments, identification of the causative substance, patenting and functionality labelling. - FY2024AdvancedAnnual report
「In research into acai's haematopoietic function, the company is pursuing clinical experiments, identification of the causative substance and patenting in order to make the value demonstrated by its research results widely known to customers through functionality labelling.」
Research into haematopoietic function has progressed from a general explanation of continuing research to specific next-stage initiatives, including clinical experiments, identification of the causative substance and patenting. - FY2024-Q2AdvancedAnnual report
「In research into acai's haematopoietic function, the company is pursuing clinical experiments, identification of the causative substance and patenting in order to make the value demonstrated by its research results widely known to customers through functionality labelling.」
Research into haematopoietic function has progressed from a general explanation of continuing research to specific next-stage initiatives, including clinical experiments, identification of the causative substance and patenting. - FY2024-Q1RestatedAnnual report
「We will implement marketing strategies based on consumer outreach and motivation arising from functionality analysis. By reassessing acai's intrinsic value, we will seek to raise performance in existing channels as well.」
The company continues its policy of using functionality analysis for marketing and to improve sales through existing channels. No completion of new functionality labelling is described. - FY2023AdvancedAnnual report
「Research into acai's haematopoietic function is proceeding as planned, including clinical trials and additional research into the active components, with the aim of obtaining functionality labelling. While awaiting publication of the University of Toronto's paper on anti-inflammatory effects, the company is continuing its own research to explore acai's potential and enhance its value, and is preparing new papers through joint research with research institutions.」
Research into haematopoietic function has progressed to clinical trials and additional research into the active components, and the company is preparing new paper publications in addition to the University of Toronto's research. Obtaining functionality labelling remains a stated objective. - FY2023-Q3RestatedAnnual report
「With regard to R&D, we continue to research acai's haematopoietic function, and the work is progressing smoothly.」
Research into acai's haematopoietic function continues. No completion of new functionality labelling is described. - FY2023-Q2RestatedAnnual report
「With regard to R&D, we continue to research acai's haematopoietic function, and the work is progressing smoothly.」
Research into acai's haematopoietic function continues, but no new research results or completion of functionality labelling are described. - FY2022AdvancedAnnual report
「Research into acai's haematopoietic function is proceeding as planned, including clinical trials and additional research into the active components, with the aim of obtaining functionality labelling. Joint research with the University of Toronto into acai's anti-inflammatory effects is also ongoing.」
Research into haematopoietic function has progressed to clinical trials and additional research into the active components, while joint research with the University of Toronto into anti-inflammatory effects is continuing. Obtaining functionality labelling remains a target. - FY2022-Q3RestatedAnnual report
「While considering obtaining designations such as Foods with Function Claims, the company will continue functionality research and reflect it in future sales promotions. It will also work on new product development, including considering functional supplements as a new business.」
The company continues its policy of using functionality research to obtain designations such as Foods with Function Claims, support sales promotions and develop supplements. No completion of the designation process is described. - FY2022-Q1RaisedAnnual report
「While considering obtaining designations such as Foods with Function Claims and Foods for Specified Health Uses, we will continue actively advancing functionality research and reflecting it in future sales promotions. We will also work on product development, including considering the development of functional supplements as a new business.」
The company has expanded the scope of its functionality research from sales promotion to obtaining designations such as Foods with Function Claims and Foods for Specified Health Uses, as well as developing supplements. - FY2021AdvancedAnnual report
「The University of Toronto in Canada began on 25 January 2021 a validation experiment to use the company's acai raw material in clinical research currently being conducted in Canada and Brazil into its effect in reducing the severity of NLRP3-induced inflammation*1 in patients with COVID-19 (hereinafter, "COVID-19").」
In addition to research with Chiba University and other institutions, the company began a validation experiment on 25 January 2021 using its raw material for clinical research related to COVID-19 by the University of Toronto. The scope of collaboration in functionality research and the experimental work have progressed to a specific stage. - FY2021-Q3AdvancedAnnual report
「We have also begun actively supporting clinical research being conducted by the University of Toronto into the anti-inflammatory effects of acai on COVID-19.」
In addition to the existing joint research with Chiba University, the company began supporting clinical research by the University of Toronto into the anti-inflammatory effects of acai on COVID-19, broadening the scope of its research collaboration. - FY2021-Q2RaisedAnnual report
「We will continue advancing functionality research, form partnerships with research institutions in Japan and overseas, and expand the scope of our research. We also intend to pursue initiatives that include the development of functional supplements.」
The company has broadened the scope of its functionality research to include partnerships with research institutions in Japan and overseas, expanded research coverage and the development of supplements. - FY2021-Q1ReframedAnnual report
「Looking ahead to the COVID-19 era, we will seek to strengthen sales by promoting acai's haematopoietic functionality to major food and beverage manufacturers as evidence that it may increase resistance to disease.」
The company has shifted from presenting the results of functionality research to using acai's haematopoietic functionality to promote sales to major food and beverage manufacturers. - FY2020AdvancedAnnual report
「In July 2019, at a research presentation on acai's haematopoietic function, Takahiko Shimizu (清水 孝彦), then an associate professor at the Graduate School of Medicine, Chiba University, and currently project leader of the Ageing Stress Response Research Project Team at the National Center for Geriatrics and Gerontology, reported on acai's haematopoietic function. Subsequently, the research findings were published in the international scientific journal Nutrients in February 2020.」
The research with Chiba University progressed to concrete results, including a presentation on haematopoietic function and publication in an international scientific journal. In addition, the company began human efficacy testing with the Yamanashi Gakuin University track and field team. - FY2020-Q2AdvancedAnnual report
「Under these circumstances, in July 2019 the company and Chiba University presented research findings on "the effect of acai's haematopoietic function in improving anaemia."」
The joint research with Chiba University progressed to a specific results stage, with a July 2019 presentation on acai's haematopoietic function and its effect in improving anaemia. - FY2020-Q1AdvancedAnnual report
「The company has conducted joint research with Chiba University on acai's functionality. A presentation on joint research into "acai's haematopoietic function" was scheduled for 31 July 2019. Based on the research finding that acai's haematopoietic function may help improve anaemia, the company launched the "Energised by Acai Project," focusing its PR activities on athletes and promoting the findings to consumers in an effort to restore performance.」
The joint research with Chiba University progressed to a presentation on 31 July 2019 concerning acai's haematopoietic function, and a new project was launched to link the research findings to PR aimed at athletes and consumer outreach. - FY2019RestatedAnnual report
「We have worked with relevant institutions on functionality research to date, and going forward we will not only use the results to support sales but also work to uncover new needs, including for supplements.」
The company has reaffirmed its policy of continuing functionality research with relevant institutions and linking the results to sales and the development of new products such as supplements. No new verification results are described as complete. - FY2019-Q3RestatedAnnual report
「Analysing the functionality of acai and other Amazonian fruits is extremely important, and the company is actively conducting functionality research centred on R&D commissioned from universities and other research institutions. Going forward, it will link evidence of acai's benefits to the development of new products such as supplements while communicating it to customers, thereby uncovering new needs.」
The company continues its policy of commissioning research from universities and other research institutions and linking evidence of functionality to the development of new products such as supplements. No new verification results or completion of functionality labelling are described. - FY2019-Q2RestatedAnnual report
「Analysing the functionality of acai and other Amazonian fruits is extremely important, and the company is actively conducting functionality research centred on R&D commissioned from universities and other research institutions. Going forward, it will link evidence of acai's benefits to the development of new products such as supplements while communicating it to customers, thereby uncovering new needs.」
The company continues its policy of commissioning research from universities and other research institutions and linking evidence of functionality to the development of new products such as supplements. - FY2018RestatedAnnual report
「In August 2016, the company entered into a joint research agreement with National University Corporation Chiba University concerning the functionality of acai. With the goal of "using Amazonian superfood ingredients to advance preventive medicine and sports nutrition," it continues to work to verify acai's effects in activating the brain and cells and enhancing physical strength.」
The company continues its joint research with Chiba University and research into acai's functionality. No new verification results or completion of functionality labelling are described. - FY2018-Q2RestatedAnnual report
「The company will continue working to promote sales by broadening awareness of acai's functionality and recognition in Japan.」
The company continues to pursue a policy of increasing awareness of acai's functionality and recognition in Japan. No new research agreement or verification results are described. - FY2017AdvancedAnnual report
「In August 2016, the company entered into a joint research agreement with National University Corporation Chiba University concerning the functionality of acai. With the goal of "using Amazonian superfood ingredients to advance preventive medicine and sports nutrition," it is working to verify acai's effects in activating the brain and cells and enhancing physical strength.」
The company stated that the joint research with Chiba University has been contracted and that the subjects of verification and research objectives have been defined. - FY2017-Q2AdvancedAnnual report
「Meanwhile, we are also conducting joint research with Chiba University to establish the functionality of acai and raise consumer awareness of it.」
The initiative to establish evidence of acai's functionality has progressed to a specific collaboration through joint research with Chiba University. - FY2016First statedAnnual report
「We will promote the verification of evidence regarding the benefits and effects of acai and Amazonian fruits and work to make it possible to label their functionality.」
A policy of advancing R&D, including functionality analysis, to enable functionality labelling.